http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109512892-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109512892-B |
| titleOfInvention | Pharmaceutical composition for preventing or treating idiopathic diffuse pulmonary fibrosis |
| abstract | The invention relates to a pharmaceutical composition for preventing or treating idiopathic diffuse pulmonary fibrosis, which comprises a lignan compound as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition can be used for preventing and treating pulmonary fibrosis, especially idiopathic diffuse pulmonary fibrosis, can obviously improve the exercise endurance capacity and the lung function of patients, and improve the life quality of the patients. |
| priorityDate | 2018-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.